Delivery Order SPE2DB22D1017-SPE2DB25FYRAC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packaging) with a ceiling value of $10,683.54. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a contract value of $4,488.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract value of $4,019.94 and a completion date of September 22, 2025. This is a firm fixed-price, non-competitive set-aside delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in...
- The Defense Logistics Agency awarded a $1,353.29 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on August 21, 2025, with completion expected by August 22, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction executed under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) under a firm fixed price contract valued at $4,394.88. The award, issued on September 19, 2025, is scheduled for completion by September 22, 2025, and represents a non-set-aside, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $4,048.75. This delivery order represents a firm fixed price contract with no set-aside designation, indicating it was awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $34,205.26 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,537.02 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains...
- The Defense Logistics Agency awarded a $1,736.21 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units). This firm fixed price contract, which is not set-aside and was competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by September 4, 2025, with performance at AmerisourceBergen's...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRACDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a contract ceiling value of $2,339.36. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate completion date of September 18, 2025, reflecting the expedited nature of this delivery order. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The Carvedilol ER order supports DLA's ongoing pharmaceutical supply chain operations, providing a cardiovascular medication for use across federal healthcare beneficiaries. The company's federal contracting history demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/17/25 |